- Home
- DSGX vs PEN Comparison
DSGX vs PEN Comparison
Compare DSGX & PEN Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- DSGX
- PEN
- Stock Information
- Founded
- DSGX 1981
- PEN 2004
- Country
- DSGX Canada
- PEN United States
- Employees
- DSGX N/A
- PEN N/A
- Industry
- DSGX Computer Software: Prepackaged Software
- PEN Medical/Dental Instruments
- Sector
- DSGX Technology
- PEN Health Care
- Exchange
- DSGX Nasdaq
- PEN Nasdaq
- Market Cap
- DSGX 8.8B
- PEN 10.1B
- IPO Year
- DSGX 1999
- PEN 2015
- Fundamental
- Price
- DSGX $101.87
- PEN $238.44
- Analyst Decision
- DSGX Buy
- PEN Strong Buy
- Analyst Count
- DSGX 7
- PEN 16
- Target Price
- DSGX $125.14
- PEN $302.40
- AVG Volume (30 Days)
- DSGX 453.2K
- PEN 404.1K
- Earning Date
- DSGX 09-03-2025
- PEN 07-29-2025
- Dividend Yield
- DSGX N/A
- PEN N/A
- EPS Growth
- DSGX 17.84
- PEN N/A
- EPS
- DSGX 1.65
- PEN 1.08
- Revenue
- DSGX $668,391,000.00
- PEN $1,240,100,000.00
- Revenue This Year
- DSGX $11.87
- PEN $14.60
- Revenue Next Year
- DSGX $13.36
- PEN $14.24
- P/E Ratio
- DSGX $61.29
- PEN $221.29
- Revenue Growth
- DSGX 13.74
- PEN 13.17
- 52 Week Low
- DSGX $90.61
- PEN $148.00
- 52 Week High
- DSGX $124.31
- PEN $310.00
- Technical
- Relative Strength Index (RSI)
- DSGX 46.22
- PEN 26.12
- Support Level
- DSGX $101.06
- PEN $240.12
- Resistance Level
- DSGX $104.41
- PEN $253.94
- Average True Range (ATR)
- DSGX 2.38
- PEN 5.78
- MACD
- DSGX 0.49
- PEN -0.66
- Stochastic Oscillator
- DSGX 54.96
- PEN 10.05
About DSGX Descartes Systems Group Inc. (The)
Descartes Systems Group provides a software solution that allows users in the shipping industry to communicate with one another. Its core product is the Global Logistics Network, which is best understood as transaction-driven. Descartes charges clients to send/receive messages, data, and documents on the GLN. Customers typically contract for a monthly minimum over a multiyear period. The GLN platform allows Descartes to upsell additional software modules as well, typically provided via a software-as-a-service model.
About PEN Penumbra Inc.
Penumbra Inc develops and manufactures medical devices for the neurovascular and peripheral vascular markets. Its products are sold to hospitals and are developed for use by specialist physicians. Within the neurovascular business, the firm offers products for neurovascular access, ischemic stroke, neurovascular embolization, and neurosurgical tool markets. In the peripheral vascular business, the firm sells devices related to peripheral embolization and peripheral thrombectomy. It operates as one reportable segment and its business activity consists of the design, development, manufacturing and marketing of inventive medical products.